6,000
Participants
Start Date
October 15, 2020
Primary Completion Date
November 15, 2022
Study Completion Date
June 30, 2025
Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)
Post-implementation of targeted normoxemia through oxygen titration for individual patients. Interventions for treatment of hypoxemia will follow usual local practice. Interventions for treatment of hyperoxemia (SpO2 \>96% or PaO2 \>100 mmHg) will involve down titration of FiO2 (or supplemental oxygen for non-mechanically ventilated patients) within a time frame based on local site preferences-typically in increments of no greater than 0.10 until goal oxygenation in the normoxemia range is achieved (including room air \[no supplemental oxygen\] for non-mechanically ventilated patients).
University of Pittsburgh Medical Center, Pittsburgh
University of Alabama-Birmingham Medical Center, Birmingham
Vanderbilt University Medical Center, Nashville
University of Cincinnati Medical Center, Cincinnati
The University of Texas Health Science Center at Houston, Houston
Brooke Army Medical Center, Fort Sam Houston
Denver Health, Denver
Oregon Health and Sciences University, Portland
United States Department of Defense
FED
University of Colorado, Denver
OTHER